Associates Venrock IV Net Worth & Insider Trades

Associates Venrock IV Bellerophon Therapeutics, Inc

As of October 28, 2019

What is Associates Venrock IV's Net Worth?

The current estimated net worth of Bellerophon Therapeutics, Inc's Associates Venrock IV is estimated to be about $19.55M . Associates Venrock IV owns about 6,435,173 units of Bellerophon Therapeutics, Inc common stock. In the last year at Bellerophon Therapeutics, Inc, Associates Venrock IV has sold an estimated value of $1.05M worth.

What is Associates Venrock IV's Past Insider Trading?

Associates Venrock IV's largest purchase order was 475,000 units , worth over $558.39K on September 12, 2018. Associates Venrock IV's largest sale order was 1,093,847 units , worth over $524.96K on October 28, 2019. In total, Associates Venrock IV has made about 12 transactions over a year of their time at Bellerophon Therapeutics, Inc. Associates Venrock IV usually trades in September, with the busiest year in 2018.

ASSOCIATES VENROCK IV, Venrock Healthcare Capital Partners III LP, VHCP CoInvestment Holdings III LLC, Nimish Shah, VHCP Management III LLC

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Associates Venrock IV's' Mailing Address?

  • Mailing address is 3340 Hillview Avenue Palo Alto CA 94304 CA

What are Bellerophon Therapeutics, Inc's Past Insider Trades?

Bellerophon Therapeutics, Inc's most recent insider trade came on March 22, 2021 by New Mountain Investments Ii Llc, New Mountain Capital Llc and Steven Klinsky who sold 400,000 units worth $2.19M . In the last 6 years, insiders at Bellerophon Therapeutics, Inc have sold an estimated value of $4.02M and bought an estimated value of $74.83M worth of shares. Insider trading is most common in September, with the busiest year in 2018. The most active traders at the company are Jonathan M Peacock,  Theodore T Wang,  and Peter Fernandes, PRINCIPAL EXECUTIVE OFFICER .

Bellerophon Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1